Author

Bingyu Xiu

Harvard University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Adam P. JonesiD· 2 shared Alona MuzikanskyiD· 2 shared Jie CheniD· 2 shared Konstantina M. StankovićiD· 2 shared Lei XuiD· 2 shared Limeng WuiD· 2 shared Lukas David LandeggeriD· 2 shared Scott Randall PlotkiniD· 2 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Adam P. JonesORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Enhanced Tumor Control and Hearing Loss Prevention Achieved with Combined Immune Checkpoint Inhibitor and Anti-VEGF Therapy in Vestibular Schwannoma Model

Simeng Lu, Zhenzhen Yin, Limeng Wu, Yao Sun, Jie Chen, Lai Man Natalie Wu, Janet L. Oblinger, Day Caven Blake, Bingyu Xiu, Lukas David Landegger, Richard Seist, William W. Ho, Adam P. Jones, Alona Muzikansky, Konstantina M. Stanković, , Lei Xu

Nature Communications · Feb 11, 2026Peer-reviewedCancer Biology

Direct and abscopal anti-tumor responses elicited by peripheral nerve schwannoma irradiation synergize with anti-PD1 treatment in vestibular schwannoma models

Zhenzhen Yin, Simeng Lu, Limeng Wu, Yao Sun, David W. Blake, Jie Chen, Lukas David Landegger, William W. Ho, Bingyu Xiu, Adam P. Jones, Alona Muzikansky, Helen Alice Shih, Konstantina M. Stanković, Scott Randall Plotkin, Lei Xu

This study shows that combining anti-PD1 treatment with radiation therapy for vestibular schwannomas improves tumor control, reduces radiation dose, and elicits systemic anti-tumor effects.

bioRxiv · Dec 29, 2024 · PreprintCancer Biology